Investors scored big wins last year as the S&P 500, the Nasdaq, and the Dow Jones Industrial Average all climbed by double ...

U.S. stock futures are pointing higher ahead of a closely watched inflation report; JPMorgan Chase shares are moving higher ...

Investors scored big wins last year as the S&P 500, the Nasdaq, and the Dow Jones Industrial Average all ... Image source: Getty Images. Eli Lilly (NYSE: LLY) is the maker of one of today's ...

Eight of the 30 Dow components lost value in 2024. Here's a quick look at each company, to help you determine which dividend ...

Inflation data this week has come in below forecasts. Earnings season is off to a solid start. Is this the medicine the ...

U.S. stocks are rallying after financial markets worldwide got a shot of adrenaline from an encouraging update on U.S.

US stocks gave up early gains to end mixed. Investors await key consumer inflation data and the start of earnings season on ...

Eli Lilly and Company LLY dropped 6.6% in the Jan. 14 trading session after slashing its revenue guidance for the fourth quarter and fiscal 2024, citing lower-than-expected sales for its weight-loss ...

The Dow Jones Industrial Average (DJIA) rose sharply ... This process ensures the integrity, relevance, and value of our content for our readers. Lilly Mwogah is a finance writer specializing in ...

Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn's disease, an inflammatory bowel disease that causes chronic abdominal pain.